Franklin Resources Inc Opti Nose, Inc. Transaction History

Franklin Resources Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 10, 2021	SELL	$3.2 - $4.98 $3.96 Million - $6.16 Million	-1,236,935 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$3.69 - $7.09 $745,988 - $1.43 Million	-202,165 Reduced 14.05%	1,236,935 $4.82 Million
Q1 2020 May 13, 2020	BUY	$3.49 - $9.2 $657,865 - $1.73 Million	188,500 Added 15.07%	1,439,100 $6.46 Million
Q4 2019 Feb 12, 2020	BUY	$6.27 - $11.41 $4.04 Million - $7.34 Million	643,700 Added 106.06%	1,250,600 $11.5 Million
Q2 2018 Aug 14, 2018	BUY	$18.75 - $28.46 $11.4 Million - $17.3 Million	606,900 New	606,900 $17 Million

5.29M

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $481M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.